Showing results (71-80 of 978) with videos related to

Sort By:
Pageof 98
European Journal of Clinical Pharmacology|January 1, 1991
Superior local tolerability of human versus salmon calcitonin preparations in young healthy volunteersC Wüster, W Schurr, S Scharla, et al.
Deutsche Medizinische Wochenschrift (1946)|February 7, 1997
[Mutations of ret-proto-oncogene in thyroid medullary carcinoma]K Frank-Raue, W Höppner, H Buhr, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1996
Application of genetic screening in families with hereditary medullary thyroid carcinomaK Frank-Raue, W Höppner, H Buhr, et al.
Clinical Endocrinology|September 1, 1992
Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancyE Blind, F Raue, J Götzmann, et al.
Clinical Endocrinology|January 1, 1995
Somatostatin receptor imaging in persistent medullary thyroid carcinomaK Frank-Raue, H Bihl, U Dörr, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|September 1, 1995
1,25-Dihydroxyvitamin D3 stimulates growth and inhibits calcitonin secretion in a human C cell carcinoma cell lineM Lazaretti-Castro, A Grauer, R Baier, et al.
Thyroid : Official Journal of the American Thyroid Association|January 1, 1992
Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterizationK Frank-Raue, F Raue, H J Buhr, et al.
Journal of Endocrinological Investigation|February 1, 1992
Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinomaE Blind, F Raue, T Klaiber, et al.
Pageof 98